AstraZeneca to supply nine million more vaccines to EUThe diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to Share XAstraZeneca to supply nine million more vaccines to EUhttps://pharmaphorum.com/news/astrazeneca-to-supply-nine-million-more-vaccines-to-eu/
Trials of Valneva COVID-19 vaccine begin in UKTrials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the Share XTrials of Valneva COVID-19 vaccine begin in UKhttps://pharmaphorum.com/news/trials-of-fifth-covid-19-vaccine-begin-in-uk/
Valneva accelerates Lyme disease vaccine R&D project with PfizerValneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a Share XValneva accelerates Lyme disease vaccine R&D project with Pfizerhttps://pharmaphorum.com/news/valneva-accelerates-lyme-disease-vaccine-rd-project-with-pfizer/
UK extends COVID-19 vaccine supply deal with ValnevaThe UK government has signed a €1.4 billion ($1.66 billion) order for up to 190 million doses of Share XUK extends COVID-19 vaccine supply deal with Valnevahttps://pharmaphorum.com/news/uk-extends-covid-19-vaccine-supply-deal-with-valneva/
UK announces COVID-19 vaccine deals with BioNTech/Pfizer and ValnevaThe UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses Share XUK announces COVID-19 vaccine deals with BioNTech/Pfizer and Valnevahttps://pharmaphorum.com/news/uk-announces-covid-19-vaccine-deals-with-biontechl-pfizer-and-valneva/
